Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Tweaks IND Clinical Hold Policy As Number Of Holds Rises

Mar 01 2018

• By Brenda Sandburg

Closed up finger on keyboard with word CLINICAL TRIALS

Related Content

Dynavax's Hep B Vaccine Finally Clears US FDA With Clean Label But Larger Safety Study

Nov 13 2017

FDA Clinical Hold Hits Keytruda Multiple Myeloma Studies

Jul 06 2017

Deal Watch: Vertex Selects First Candidate Under CRISPR Gene-Editing Collaboration

Dec 13 2017

Merck’s Heplisav Gets FDA Clinical Hold

Mar 17 2008

A Cellectis Trial Death Points To Challenges Ahead For CAR-T

Sep 05 2017

What Was On Hold Is New Again As Impact Raises $22.5m For Fedratinib

Oct 13 2017

Related Companies

Cellectis SA

Merck & Co., Inc.

Sanofi

Impact Biomedicines, Inc.

Dynavax Technologies Corporation

Additional Topics

United States Regulation FDA Clinical Trials BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window